159 related articles for article (PubMed ID: 17426086)
1. Effects of testosterone therapy on cardiovascular risk markers in androgen-deficient women with hypopituitarism.
Miller KK; Biller BM; Schaub A; Pulaski-Liebert K; Bradwin G; Rifai N; Klibanski A
J Clin Endocrinol Metab; 2007 Jul; 92(7):2474-9. PubMed ID: 17426086
[TBL] [Abstract][Full Text] [Related]
2. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study.
Miller KK; Biller BM; Beauregard C; Lipman JG; Jones J; Schoenfeld D; Sherman JC; Swearingen B; Loeffler J; Klibanski A
J Clin Endocrinol Metab; 2006 May; 91(5):1683-90. PubMed ID: 16478814
[TBL] [Abstract][Full Text] [Related]
3. Effects of transdermal testosterone on natriuretic peptide levels in women: a randomized placebo-controlled pilot study.
Lin E; McCabe E; Newton-Cheh C; Bloch K; Buys E; Wang T; Miller KK
Fertil Steril; 2012 Feb; 97(2):489-93. PubMed ID: 22137497
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory cardiovascular risk markers in women with hypopituitarism.
Sesmilo G; Miller KK; Hayden D; Klibanski A
J Clin Endocrinol Metab; 2001 Dec; 86(12):5774-81. PubMed ID: 11739438
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study.
Beauregard C; Utz AL; Schaub AE; Nachtigall L; Biller BM; Miller KK; Klibanski A
J Clin Endocrinol Metab; 2008 Jun; 93(6):2063-71. PubMed ID: 18381581
[TBL] [Abstract][Full Text] [Related]
6. Androgens in relationship to cardiovascular risk factors in the menopausal transition.
Mesch VR; Siseles NO; Maidana PN; Boero LE; Sayegh F; Prada M; Royer M; Schreier L; Benencia HJ; Berg GA
Climacteric; 2008; 11(6):509-17. PubMed ID: 18991078
[TBL] [Abstract][Full Text] [Related]
7. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial.
Johannsson G; Burman P; Wirén L; Engström BE; Nilsson AG; Ottosson M; Jonsson B; Bengtsson BA; Karlsson FA
J Clin Endocrinol Metab; 2002 May; 87(5):2046-52. PubMed ID: 11994339
[TBL] [Abstract][Full Text] [Related]
8. Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels.
Dougherty RH; Rohrer JL; Hayden D; Rubin SD; Leder BZ
Clin Endocrinol (Oxf); 2005 Feb; 62(2):228-35. PubMed ID: 15670201
[TBL] [Abstract][Full Text] [Related]
9. Androgens and bone density in women with hypopituitarism.
Miller KK; Biller BM; Hier J; Arena E; Klibanski A
J Clin Endocrinol Metab; 2002 Jun; 87(6):2770-6. PubMed ID: 12050248
[TBL] [Abstract][Full Text] [Related]
10. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
11. Effects of transdermal testosterone administration on insulin sensitivity, fat mass and distribution, and markers of inflammation and thrombolysis in human immunodeficiency virus-infected women with mild to moderate weight loss.
Herbst KL; Calof OM; Hsia SH; Sinha-Hikim I; Woodhouse LJ; Buchanan TA; Bhasin S
Fertil Steril; 2006 Jun; 85(6):1794-802. PubMed ID: 16759927
[TBL] [Abstract][Full Text] [Related]
12. Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study.
Piltonen T; Puurunen J; Hedberg P; Ruokonen A; Mutt SJ; Herzig KH; Nissinen A; Morin-Papunen L; Tapanainen JS
Hum Reprod; 2012 Oct; 27(10):3046-56. PubMed ID: 22811306
[TBL] [Abstract][Full Text] [Related]
13. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.
Weaver JU; Monson JP; Noonan K; John WG; Edwards A; Evans KA; Cunningham J
J Clin Endocrinol Metab; 1995 Jan; 80(1):153-9. PubMed ID: 7829604
[TBL] [Abstract][Full Text] [Related]
14. Androgen replacement therapy in androgen-deficient women with hypopituitarism.
Zang H; Davis SR
Drugs; 2008; 68(15):2085-93. PubMed ID: 18840000
[TBL] [Abstract][Full Text] [Related]
15. Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss.
Choi HH; Gray PB; Storer TW; Calof OM; Woodhouse L; Singh AB; Padero C; Mac RP; Sinha-Hikim I; Shen R; Dzekov J; Dzekov C; Kushnir MM; Rockwood AL; Meikle AW; Lee ML; Hays RD; Bhasin S
J Clin Endocrinol Metab; 2005 Mar; 90(3):1531-41. PubMed ID: 15613414
[TBL] [Abstract][Full Text] [Related]
16. Testosterone dose-response relationships with cardiovascular risk markers in androgen-deficient women: a randomized, placebo-controlled trial.
Huang G; Tang E; Aakil A; Anderson S; Jara H; Davda M; Stroh H; Travison TG; Bhasin S; Basaria S
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1287-93. PubMed ID: 24712568
[TBL] [Abstract][Full Text] [Related]
17. Androgen deficiency in hypopituitary women: its consequences and management.
Esposito D; Tivesten Å; Olivius C; Ragnarsson O; Johannsson G
Rev Endocr Metab Disord; 2024 Jun; 25(3):479-488. PubMed ID: 38240912
[TBL] [Abstract][Full Text] [Related]
18. Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency.
Petersons CJ; Mangelsdorf BL; Thompson CH; Burt MG
J Clin Endocrinol Metab; 2014 Jun; 99(6):2269-76. PubMed ID: 24606100
[TBL] [Abstract][Full Text] [Related]
19. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
Undén AL; Elofsson S; Brismar K
Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
[TBL] [Abstract][Full Text] [Related]
20. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
